Literature DB >> 19784720

Surgical treatment of hepatocellular carcinoma.

Kiyoshi Hasegawa1, Norihiro Kokudo.   

Abstract

Local tumor control is still the most important consideration in the treatment of hepatocellular carcinoma (HCC). Surgical treatments, including liver resection and liver transplantation are, and will remain, the first-line therapeutic strategies for local control in patients with primary HCC. Although aggressive liver resection is often performed for advanced HCC in patients with a large tumor, multiple tumors, or tumors with vascular invasion, liver transplantation is the preferred option, after taking into consideration age and tumor-related factors, when there is poor liver functional reserve. Preventing deterioration in liver function is the second priority in the treatment of HCC. When performing liver resection, extensive removal of noncancerous liver parenchyma during lobectomy or hemihepatectomy, should be avoided as much as possible. Anatomic resection, which refers to systematic elimination of the main tumor with its minute metastases, preserves liver function and is highly recommended. A treatment algorithm based on published evidence is now available, which helps us decide on the most suitable therapeutic option for individual patients, depending on the tumor characteristics and liver functional reserve.

Entities:  

Mesh:

Year:  2009        PMID: 19784720     DOI: 10.1007/s00595-008-4024-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  108 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Hanging maneuver in left hepatectomy.

Authors:  Kyung-Suk Suh; Hyuk-Joon Lee; Seong Hoon Kim; Sang Beom Kim; Kuhn Uk Lee
Journal:  Hepatogastroenterology       Date:  2004 Sep-Oct

3.  Liver transplantation for hepatocellular carcinoma in cirrhosis: prognostic parameters.

Authors:  C Benckert; S Jonas; A Thelen; A Spinelli; G Schumacher; M Heise; J Langrehr; P Neuhaus
Journal:  Transplant Proc       Date:  2005-05       Impact factor: 1.066

4.  Adult-to-adult living donor liver transplantation using extended right lobe grafts.

Authors:  C M Lo; S T Fan; C L Liu; W I Wei; R J Lo; C L Lai; J K Chan; I O Ng; A Fung; J Wong
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

5.  Repeat hepatic resection for recurrent hepatocellular carcinoma.

Authors:  T Kakazu; M Makuuchi; S Kawasaki; S Miyagawa; Y Hashikura; T Kosuge; T Takayama; J Yamamoto
Journal:  Hepatogastroenterology       Date:  1993-08

6.  Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy.

Authors:  C Huguet; B Nordlinger; P Bloch; J Conard
Journal:  Arch Surg       Date:  1978-12

7.  Management of adrenal metastasis from hepatocellular carcinoma.

Authors:  Hirohito Momoi; Yasuyuki Shimahara; Hiroaki Terajima; Yuji Iimuro; Naritaka Yamamoto; Yuzo Yamamoto; Iwao Ikai; Yoshio Yamaoka
Journal:  Surg Today       Date:  2002       Impact factor: 2.549

8.  Liver transplantation for hepatocellular carcinoma: the MELD impact.

Authors:  Pratima Sharma; Vijayan Balan; Jose L Hernandez; Ann M Harper; Erick B Edwards; Hector Rodriguez-Luna; Thomas Byrne; Hugo E Vargas; David Mulligan; Jorge Rakela; Russell H Wiesner
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

9.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Taku Aoki; Michiro Takahashi; Yosuke Inoue; Keiji Sano; Hiroshi Imamura; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

10.  Preemptive therapy for hepatitis C virus after living-donor liver transplantation.

Authors:  Yasuhiko Sugawara; Masatoshi Makuuchi; Yuichi Matsui; Yoji Kishi; Nobuhisa Akamatsu; Junichi Kaneko; Norihiro Kokudo
Journal:  Transplantation       Date:  2004-11-15       Impact factor: 4.939

View more
  24 in total

1.  Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case.

Authors:  Tatsuaki Sumiyoshi; Michihisa Moriguchi; Hideyuki Kanemoto; Kouiku Asakura; Keiko Sasaki; Teiichi Sugiura; Takashi Mizuno; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2011-12-10       Impact factor: 2.549

2.  Intra-hepatic arterioportal shunt mimicking a metastatic liver tumor: report of a case.

Authors:  Koichiro Haruki; Shigeki Wakiyama; Hiroaki Shiba; Yuichi Ishida; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

3.  Ultrasound-guided microwave coagulation assists anatomical hepatic resection.

Authors:  Satoru Imura; Mitsuo Shimada; Tohru Utsunomiya; Yuji Morine; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Shuichi Iwahashi; Yu Saito; Hidenori Miyake
Journal:  Surg Today       Date:  2011-11-12       Impact factor: 2.549

4.  Total resection of the right hepatic vein drainage area with the aid of three-dimensional computed tomography.

Authors:  Akinobu Taketomi; Kazuki Takeishi; Yohei Mano; Takeo Toshima; Takashi Motomura; Shinichi Aishima; Hideaki Uchiyama; Tomoharu Yoshizumi; Ken Shirabe; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-11       Impact factor: 2.549

5.  Small intestinal metastasis from intrahepatic cholangiocarcinoma: report of a case.

Authors:  Hironori Hayashi; Takashi Tani; Hidehiro Tajima; Yasuhiro Shoji; Shiro Terai; Ichiro Onishi; Hiroyuki Takamura; Hirohisa Kitagawa; Masato Kayahara; Tetsuo Ohta
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

6.  Impact of Glissonean pedicle approach for centrally located hepatocellular carcinoma in mongolia.

Authors:  Jigjidsuren Chinburen; Michele Gillet; Masakazu Yamamoto; Tsiiregzen Enkh-Amgalan; Erdenebileg Taivanbaatar; Chinbold Enkhbold; Puntsagdulam Natsagnyam
Journal:  Int Surg       Date:  2015-02

7.  Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysis.

Authors:  Shinji Itoh; Ken Shirabe; Akinobu Taketomi; Kazutoyo Morita; Norifumi Harimoto; Eiji Tsujita; Keishi Sugimachi; Yo-Ichi Yamashita; Tomonobu Gion; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-12-27       Impact factor: 2.549

8.  Hepatic resection using a liver-hanging maneuver and Glissonean pedicle transection for hepatocellular carcinoma in a patient with situs inversus totalis: report of a case.

Authors:  Kazuto Harada; Toshiro Masuda; Toru Beppu; Takatoshi Ishiko; Akira Chikamoto; Hiromitsu Hayashi; Hirohisa Okabe; Ryu Otao; Hiroshi Tanaka; Hiroshi Takamori; Hideo Baba
Journal:  Surg Today       Date:  2012-03-06       Impact factor: 2.549

9.  Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome?

Authors:  Binkui Li; Yunfei Yuan; Guihua Chen; Liru He; Yaqi Zhang; Jinqing Li; Guohui Li; Wan Yee Lau
Journal:  BMC Cancer       Date:  2010-10-07       Impact factor: 4.430

10.  Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Yukio Nakamura; Shigenori Ota; Thomas T Hui; Koichi Hirata
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.